Free Trial
NASDAQ:EVFM

Evofem Biosciences (EVFM) Stock Price, News & Analysis

Evofem Biosciences logo
$0.0091 0.00 (-2.15%)
As of 08/1/2025 03:37 PM Eastern

About Evofem Biosciences Stock (NASDAQ:EVFM)

Key Stats

Today's Range
$0.0090
$0.0096
50-Day Range
$0.0086
$0.01
52-Week Range
$0.0061
$0.0150
Volume
389,398 shs
Average Volume
416,746 shs
Market Capitalization
$1.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Evofem Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
13th Percentile Overall Score

EVFM MarketRank™: 

Evofem Biosciences scored higher than 13% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Evofem Biosciences.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Evofem Biosciences is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Evofem Biosciences is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.10% of the outstanding shares of Evofem Biosciences have been sold short.
  • Short Interest Ratio / Days to Cover

    Evofem Biosciences has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Evofem Biosciences has recently increased by 330.42%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Evofem Biosciences does not currently pay a dividend.

  • Dividend Growth

    Evofem Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.10% of the outstanding shares of Evofem Biosciences have been sold short.
  • Short Interest Ratio / Days to Cover

    Evofem Biosciences has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Evofem Biosciences has recently increased by 330.42%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Evofem Biosciences this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Evofem Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.21% of the stock of Evofem Biosciences is held by insiders.

  • Percentage Held by Institutions

    Only 0.22% of the stock of Evofem Biosciences is held by institutions.

  • Read more about Evofem Biosciences' insider trading history.
Receive EVFM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evofem Biosciences and its competitors with MarketBeat's FREE daily newsletter.

EVFM Stock News Headlines

Evofem Biosciences, Inc. (EVFM) - Yahoo Finance
A new rule goes live in July — and the banks are quietly crushing it
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Evofem Biosciences Inc. Q1 Earnings Summary
See More Headlines

EVFM Stock Analysis - Frequently Asked Questions

Evofem Biosciences' stock was trading at $0.0099 at the beginning of 2025. Since then, EVFM shares have decreased by 8.1% and is now trading at $0.0091.

Evofem Biosciences, Inc. (NASDAQ:EVFM) announced its earnings results on Friday, June, 16th. The biotechnology company reported ($1.85) earnings per share (EPS) for the quarter, topping the consensus estimate of ($15.00) by $13.15. The biotechnology company earned $5.81 million during the quarter. Evofem Biosciences had a negative trailing twelve-month return on equity of 91.97% and a negative net margin of 46.42%.

Shares of Evofem Biosciences reverse split on the morning of Thursday, May 18th 2023.The 1-125 reverse split was announced on Thursday, May 18th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of EVFM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evofem Biosciences investors own include Tesla (TSLA), NIO (NIO), Plug Power (PLUG), Meta Platforms (META), Sorrento Therapeutics (SRNE), NVIDIA (NVDA) and Ford Motor (F).

Company Calendar

Last Earnings
6/16/2023
Today
8/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:EVFM
CIK
1618835
Employees
120
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$52.98 million
Net Margins
-46.42%
Pretax Margin
-46.42%
Return on Equity
-91.97%
Return on Assets
-61.93%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.11
Quick Ratio
0.09

Sales & Book Value

Annual Sales
$11.39 million
Price / Sales
0.09
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.64) per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
118,656,000
Free Float
113,118,000
Market Cap
$1.08 million
Optionable
Not Optionable
Beta
-0.92

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:EVFM) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners